Journal Home
Search for

Volume 118, Issue 1, Pages 292-299 (May 2010)


View previous. 43 of 48 View next.

Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression

Leisa A. Glantza, John H. Gilmorea, David H. Overstreetab, Kayvon Salimia, Jeffrey A. Liebermanc, L. Fredrik JarskogcCorresponding Author Informationemail address

Received 4 September 2009; received in revised form 18 December 2009; accepted 21 December 2009. published online 13 January 2010.

Abstract 

Although the etiology of schizophrenia remains unknown, diverse neuropathological evidence suggests a disorder of synaptic connectivity. Apoptosis is a form of cell death that helps determine synaptic circuitry during neurodevelopment and altered regulation of apoptosis has been implicated in schizophrenia. Prostate apoptosis response-4 (Par-4) is an upstream regulator of apoptosis preferentially localized to synapses. Brain Par-4 levels are upregulated in response to pro-apoptotic stimuli in rodent models and in patients with classic neurodegenerative diseases. Recently, Par-4 was also found to form a complex with the dopamine D2 receptor (D2DR) in competition with the calcium-binding protein calmodulin, implicating Par-4 as an important regulatory component in normal dopamine signaling. Interestingly, mutant mice with disrupted Par-4/D2DR interaction demonstrated depressive-like behaviors, suggesting a potential role for Par-4 in both depression and schizophrenia. In this study, Par-4, D2DR and calmodulin protein levels were measured using semiquantitative Western blotting in postmortem temporal cortex in subjects with schizophrenia, major depression and bipolar disorder. Compared to normal controls, mean Par-4 levels appeared slightly lower in schizophrenia and bipolar disorder. However, in major depression, Par-4 was decreased by 67% compared to normal controls. No differences were found between any groups for calmodulin or for the D2DR 48kDa band. The D2DR 98kDa band was lower by 50% in the schizophrenia compared to control groups. Changes in the Par-4/D2DR signaling pathway represent a novel mechanism that may link apoptotic and dopamine signaling pathways in major depression and schizophrenia.

a Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA

b Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA

c Department of Psychiatry, Columbia University, New York, NY 10032, USA

Corresponding Author InformationCorresponding author. NYSPI/Columbia University, 1051 Riverside Drive, Unit #42, New York, NY 10032, USA. Tel.: +1 212 543 6711; fax: +1 212 543 1350.

PII: S0920-9964(09)00618-5

doi:10.1016/j.schres.2009.12.027


View previous. 43 of 48 View next.